Treating Hepatic Steatosis and Fibrosis by Modulating Mitochondrial Pyruvate Metabolism
Sign Up to like & getrecommendations! Published in 2019 at "Cellular and Molecular Gastroenterology and Hepatology"
DOI: 10.1016/j.jcmgh.2018.09.017
Abstract: A hepatic comorbidity of metabolic syndrome, known as nonalcoholic fatty liver disease (NAFLD), is increasing in prevalence in conjunction with the pandemics of obesity and diabetes. The spectrum of NAFLD ranges from simple hepatic fat… read more here.
Keywords: fibrosis; metabolism; disease; treating hepatic ... See more keywords